title: [Fecal microbiota transplantation in treatment of inflammatory bowel diseases].
abstract: Inflammatory bowel diseases (IBD) are chronic, recurrent disease associated with significant morbidity and disability rates and marked reduction of quality of life. The exact aetiology of these conditions is unknown, however, there is increasing data supporting the influence of gut microbiota in the pathogenesis of IBD. Despite of large number of actively exploring approaches to IBD treatment, some patients remain refractory to standard management or have significant adverse side effects. Given the probably role of the gastrointestinal microbiotain development of IBD, treatments that manipulate the microbiota have been investigated with varying degree of efficacy. Faecal microbiota transplantation (FMT) can be considered as alternative regimen for IBD management, but there is currently a lack of evidence supporting this approach in similar conditions. The comprehensive data are necessary to provide understandable and clear conclusion to guide current practice and future research.
authors.forename: M A
authors.initials: MA
authors.lastname: Privalov
authors.forename: A K
authors.initials: AK
authors.lastname: Sizenko
mesh_terms: D000285:Administration, Rectal; D004733:Enema; D005243:Feces / Q000382:microbiology; D041981:Gastrointestinal Tract / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000382:microbiology* / Q000473:pathology / Q000628:therapy*; D059013:Microbial Consortia / Q000502:physiology; D064307:Microbiota / Q000502:physiology*; D019936:Probiotics / Q000008:administration & dosage*; D011788:Quality of Life; D013559:Symbiosis / Q000502:physiology